Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Oxybutynin transdermal - AbbVie

Next Previous
Drug Profile

Oxybutynin transdermal - AbbVie

Alternative Names: CS 801; Gelnique Gel 10%; Kentera; MM 801; Oxybutynin patch - AbbVie; Oxybutynin topical gel - AbbVie; Oxytrol

Latest Information Update: 27 Apr 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Watson Laboratories
  • Developer AbbVie; Daiichi Sankyo Company; Meiji Dairies Corporation
  • Class Alkynes; Antispasmodics; Carbocyclic acids; Cyclohexanes; Diethylamines; Esters; Mandelic acids; Skin disorder therapies; Small molecules
  • Mechanism of Action Cholinergic receptor antagonists; Muscarinic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Overactive bladder

Most Recent Events

  • 23 Apr 2024 Endo International has been acquired and merged into Endo, Inc.
  • 08 May 2020 Allergan has been acquired and merged into AbbVie
  • 12 Feb 2015 Launched for Overactive bladder in Switzerland, Norway and New Zealand (Transdermal) prior to February 2015

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top